Evaluation of natural killer cell tumor homing and effector function in response to CDK4/6 and AURKA inhibition in a melanoma tumor-on-a-chip platform
Srija Chakraborty, Connor Durham, Vijaya Bharti, Marina Capece, Alexander E. Davies, Anna E. Vilgelm, Aleksander Skardal
This study evaluates how CDK4/6 and AURKA inhibition enhances NK cell homing and tumor-killing in melanoma models using tumor-on-a-chip platforms.
bioRxiv · Jul 9, 2025 · PreprintCancer Biology